A new study suggests GLP-1 weight-loss drugs may be able to do more than curb appetite. Here's what researchers found.
"This study suggests that GLP-1 drugs may offer protective benefits, potentially improving survival and recurrence risk in ...
Contrary to regulatory warnings, research shows no link between the continuation of GLP-1s following acute pancreatitis and ...
11d
Weight loss drug GLP-1 may have potential to treat depression, improve motivation, study suggests
The study found that the active ingredient in GLP-1 drugs "significantly improved" motivation in patients with major ...
The data shows that the drugs triggered activity in the central amygdala that reduced dopamine release into the brain's reward circuitry.
A retrospective cohort study suggested that GLP-1 receptor agonists may be linked to reduced recurrence in breast cancer ...
A National Institutes of Health (NIH)-funded study has found that an emerging class of GLP-1 weight-loss drugs suppress ...
SurvivorNet on MSN
Transformed By GLP-1 Weight Loss & Refusing To Be Stigmatized– Resilient Despite Surprising Negative Attitudes Revealed in New Study
As weight loss supported by GLP-1 drugs increases nationwide, new research suggests that stigma toward users still ...
A new study from researchers at Cambridge, Mass.-based Harvard University found that blockbuster GLP-1 drugs such as Ozempic and Zepbound may have a minimal effect on an individual’s risk of ...
MedPage Today on MSN
More evidence that GLP-1s may reduce risk of vision-robbing eye diseases
Significantly lower AMD risk compared with other agents in cohort study ...
The majority of weight loss from GLP-1 medication is from fat loss, and not muscle loss, new evidence suggests.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results